Join us for an unscripted LinkedIn Live podcast hosted by xLM Continuous Intelligence in conversation with Mr. Bob Buhlmann, a seasoned pharma leader with experience from consulting to senior roles at Amgen, now Head of Quality, Digital and Computer Strategy at AstraZeneca.

This live discussion explores how AI is applied in GxP-regulated manufacturing environments, drawing on global operations experience. Mr. Buhlmann offers a regulatory perspective, having engaged with global health authorities including the FDA (USA), EMA (EuroZone), MHRA (UK), MPA (Sweden), NMPA (China), while overseeing AIadoption across IT and manufacturing.

Expect an open, no-slides conversation on:

• How health authorities view AI in regulated manufacturing

• What actually works (and what doesn’t) when deploying AI in GxP systems

• Moving from theoretical compliance to operational impact

• How Big Pharma is taking strides across their global operations

If you’re navigating AI adoption in pharma manufacturing, quality, or compliance, this conversation is for you.

Note: All views expressed in this podcast are the views of Mr. Bob Buhlmann and DO NOT represent the views of AstraZeneca.

==**==

Nagesh Nama's thought leadership articles on Forbes & Fast Company

1️⃣https://www.fastcompany.com/91475687/...

2️⃣https://www.forbes.com/councils/forbe...

3️⃣https://www.forbes.com/councils/forbe...

==**==

xLM Coordinates

✅Website: https://www.continuousintelligence.ai/

✅LinkedIn: https://www.linkedin.com/company/xlm-llc

✅Spotify: https://spoti.fi/3ERya62

✅Beehiiv: https://continuoustv.beehiiv.com/

✅YouTube: https://www.youtube.com/@xLMContinuousTV